hydrogen sulfide has been researched along with Atherogenesis in 59 studies
Hydrogen Sulfide: A flammable, poisonous gas with a characteristic odor of rotten eggs. It is used in the manufacture of chemicals, in metallurgy, and as an analytical reagent. (From Merck Index, 11th ed)
hydrogen sulfide : A sulfur hydride consisting of a single sulfur atom bonded to two hydrogen atoms. A highly poisonous, flammable gas with a characteristic odour of rotten eggs, it is often produced by bacterial decomposition of organic matter in the absence of oxygen.
thiol : An organosulfur compound in which a thiol group, -SH, is attached to a carbon atom of any aliphatic or aromatic moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Stigmatized as a toxic environmental pollutant for centuries, hydrogen sulfide (H2S) has gained recognition over the last decade as an important gasotransmitter that functions in physiological and pathophysiological conditions, such as atherosclerosis." | 8.90 | Hydrogen sulfide and the pathogenesis of atherosclerosis. ( Mani, S; Untereiner, A; Wang, R; Wu, L, 2014) |
| "Hydrogen sulfide donors can block the cardiovascular injury of hyperhomocysteinemia." | 7.91 | Hydrogen sulfide lowers hyperhomocysteinemia dependent on cystathionine γ lyase S-sulfhydration in ApoE-knockout atherosclerotic mice. ( Cai, J; Cui, C; Cui, Q; Fan, J; Geng, B; Jiang, S; Li, S; Tang, X; Xu, G; Yang, J; Zhang, J; Zheng, F, 2019) |
| "Endogenous hydrogen sulfide (H2S), a novel gasotransmitter in cardiovascular regulation, plays an important protective role in the development and progression of atherosclerosis (AS)." | 7.81 | [Effects of hydrogen sulfide donor on production of adrenomedullin and atrial natriuretic peptide in rats with atherosclerosis]. ( Du, JB; Jin, HF; Li, W, 2015) |
| "Hydrogen sulfide, as a novel gaseous mediator, has been suggested to play a key role in atherogenesis." | 7.78 | Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression. ( Gu, T; Guo, C; Wang, C; Wang, L; Wu, D; Zhang, A; Zhang, H, 2012) |
| "Hydrogen sulfide (H(2)S) is a novel gaseous mediator that plays important roles in atherosclerosis." | 7.78 | Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice. ( Fan, Y; Gu, T; Guo, C; Sparatore, A; Wang, C; Wu, D; Zhang, A; Zhang, H, 2012) |
| "Atherosclerosis is a complex pathological condition marked by the accumulation of lipids in the arterial wall, leading to the development of plaques that can eventually rupture and cause thrombotic events." | 7.01 | Hydrogen Sulfide and Oxygen Homeostasis in Atherosclerosis: A Systematic Review from Molecular Biology to Therapeutic Perspectives. ( Munteanu, C, 2023) |
| "Hydrogen sulfide (H2S) has been shown to decrease MMP activities in all cases in the literature by acting as an antioxidant and vasodilator." | 6.52 | Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms. ( Givimani, S; Neamtu, D; Rehman, S; Tyagi, SC; Vacek, TP; Yu, S, 2015) |
| "Hydrogen sulfide (H(2)S) was the third gaseous transmitter to be discovered, along with nitric oxide and carbon monoxide, and has been proposed to be involved in numerous physiological processes and pathology of various diseases." | 6.47 | Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential. ( Austin, RC; Lynn, EG, 2011) |
| "Atherosclerosis is a chronic, complex, and progressive pathological process in large and medium sized arteries." | 6.46 | Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis. ( Chaoshu, T; Hongfang, J; Junbao, D; Qiao, W, 2010) |
| "Hydrogen sulfide (H2S) has been shown to have powerful antioxidative and anti-inflammatory properties that can regulate multiple cardiovascular functions." | 5.43 | Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation. ( Ferro, A; Gu, Y; Han, Y; Huang, Z; Ji, Y; Liu, G; Ma, Y; Meng, G; Moore, PK; Wang, H; Wang, W; Wang, X; Wang, Y; Wen, M; Xie, L; Yu, Y; Zhang, Z; Zhao, S, 2016) |
| "Hydrogen sulfide (H 2 S) plays a protective role in chronic hemodialysis (CHD) patients." | 5.42 | Correlation of Lower Concentrations of Hydrogen Sulfide with Activation of Protein Kinase CβII in Uremic Accelerated Atherosclerosis Patients. ( Feng, SJ; Li, H; Wang, SX; Wang, W; Zhang, XD, 2015) |
| "Stigmatized as a toxic environmental pollutant for centuries, hydrogen sulfide (H2S) has gained recognition over the last decade as an important gasotransmitter that functions in physiological and pathophysiological conditions, such as atherosclerosis." | 4.90 | Hydrogen sulfide and the pathogenesis of atherosclerosis. ( Mani, S; Untereiner, A; Wang, R; Wu, L, 2014) |
| "Hydrogen sulfide donors can block the cardiovascular injury of hyperhomocysteinemia." | 3.91 | Hydrogen sulfide lowers hyperhomocysteinemia dependent on cystathionine γ lyase S-sulfhydration in ApoE-knockout atherosclerotic mice. ( Cai, J; Cui, C; Cui, Q; Fan, J; Geng, B; Jiang, S; Li, S; Tang, X; Xu, G; Yang, J; Zhang, J; Zheng, F, 2019) |
| "S-sulfhydration is a signalling pathway of hydrogen sulfide (H2S), which is suggested as an anti-atherogenic molecule that may protect against atherosclerosis." | 3.88 | Hydrogen sulfide mediates athero-protection against oxidative stress via S-sulfhydration. ( Cheung, SH; Lau, JYW, 2018) |
| "To investigate antiatherosclerosis effect of atorvastatin (ATV) in a rat atherosclerosis model, and to explore roles of nitric oxide and hydrogen sulfide (H2S) in this event." | 3.81 | The roles of nitric oxide and hydrogen sulfide in the anti-atherosclerotic effect of atorvastatin. ( Cai, Y; Fan, Z; Feng, J; Jiang, F; Li, J; Liu, X; Ma, D; Zha, K; Zheng, S, 2015) |
| "Endogenous hydrogen sulfide (H2S), a novel gasotransmitter in cardiovascular regulation, plays an important protective role in the development and progression of atherosclerosis (AS)." | 3.81 | [Effects of hydrogen sulfide donor on production of adrenomedullin and atrial natriuretic peptide in rats with atherosclerosis]. ( Du, JB; Jin, HF; Li, W, 2015) |
| "Hydrogen sulfide (H2S) is an important gaseous signaling molecule that functions in physiological and pathological conditions, such as atherosclerosis." | 3.80 | Anti-atherogenic effect of hydrogen sulfide by over-expression of cystathionine gamma-lyase (CSE) gene. ( Cheung, SH; Kwok, WK; Lau, JY; To, KF, 2014) |
| "Hydrogen sulfide, as a novel gaseous mediator, has been suggested to play a key role in atherogenesis." | 3.78 | Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression. ( Gu, T; Guo, C; Wang, C; Wang, L; Wu, D; Zhang, A; Zhang, H, 2012) |
| "Hydrogen sulfide (H(2)S) is a novel gaseous mediator that plays important roles in atherosclerosis." | 3.78 | Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice. ( Fan, Y; Gu, T; Guo, C; Sparatore, A; Wang, C; Wu, D; Zhang, A; Zhang, H, 2012) |
| "This study was designed to examine the effect of sulfur dioxide (SO(2)) on atherosclerotic progression and endogenous vascular hydrogen sulfide (H(2)S) in rats with atherosclerosis (AS)." | 3.77 | Regulatory effects of sulfur dioxide on the development of atherosclerotic lesions and vascular hydrogen sulfide in atherosclerotic rats. ( Du, J; Jin, H; Li, W; Tang, C, 2011) |
| "This study aimed to explore the effect of onion extract on endogenous hydrogen sulfide (H2S) and adrenomedulin (ADM) and on atherosclerotic progression in rats with atherosclerosis (AS)." | 3.77 | Effects of onion extract on endogenous vascular H2S and adrenomedulin in rat atherosclerosis. ( Du, J; Jin, H; Li, W; Tang, C, 2011) |
| "Atherosclerosis is a complex pathological condition marked by the accumulation of lipids in the arterial wall, leading to the development of plaques that can eventually rupture and cause thrombotic events." | 3.01 | Hydrogen Sulfide and Oxygen Homeostasis in Atherosclerosis: A Systematic Review from Molecular Biology to Therapeutic Perspectives. ( Munteanu, C, 2023) |
| "Hydrogen sulfide (H2S)has emerged as pivotal signaling molecules since it is recognized as the third gasotransmitter together with nitric oxide and carbon monoxide." | 2.55 | [The Molecular Switches and Atomic Biological Mechanisms Underlying the Physiological and Pathophysio-logical Effects of Hydrogen Sulfide to Regulate Its "Receptors"]. ( Cai, WJ; Li, XH; Tao, BB; Wang, MJ; Xue, WL; Zhu, YC, 2017) |
| "Hydrogen sulfide (H2S) has been shown to decrease MMP activities in all cases in the literature by acting as an antioxidant and vasodilator." | 2.52 | Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms. ( Givimani, S; Neamtu, D; Rehman, S; Tyagi, SC; Vacek, TP; Yu, S, 2015) |
| "Hydrogen sulfide (H2S) is a biologically active gas that is synthesized naturally by three enzymes, cystathionine γ-lyase (CSE), cystathionine β-synthetase (CBS) and 3-mercaptopyruvate sulfurtransferase (3-MST)." | 2.52 | H2S Synthesizing Enzymes: Biochemistry and Molecular Aspects. ( Huang, CW; Moore, PK, 2015) |
| "Hydrogen sulfide (H(2)S) was the third gaseous transmitter to be discovered, along with nitric oxide and carbon monoxide, and has been proposed to be involved in numerous physiological processes and pathology of various diseases." | 2.47 | Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential. ( Austin, RC; Lynn, EG, 2011) |
| "Atherosclerosis is a chronic, complex, and progressive pathological process in large and medium sized arteries." | 2.46 | Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis. ( Chaoshu, T; Hongfang, J; Junbao, D; Qiao, W, 2010) |
| "Hydrogen sulfide (H2S) has been shown to have powerful antioxidative and anti-inflammatory properties that can regulate multiple cardiovascular functions." | 1.43 | Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation. ( Ferro, A; Gu, Y; Han, Y; Huang, Z; Ji, Y; Liu, G; Ma, Y; Meng, G; Moore, PK; Wang, H; Wang, W; Wang, X; Wang, Y; Wen, M; Xie, L; Yu, Y; Zhang, Z; Zhao, S, 2016) |
| "Hydrogen sulfide (H 2 S) plays a protective role in chronic hemodialysis (CHD) patients." | 1.42 | Correlation of Lower Concentrations of Hydrogen Sulfide with Activation of Protein Kinase CβII in Uremic Accelerated Atherosclerosis Patients. ( Feng, SJ; Li, H; Wang, SX; Wang, W; Zhang, XD, 2015) |
| "Hydrogen sulfide (H2S) has complex effects in inflammation with both pro- and anti-inflammatory actions of this gas reported." | 1.40 | Effect of feeding a high fat diet on hydrogen sulfide (H2S) metabolism in the mouse. ( Anwar, AB; Atan, MS; Kumar, SD; Moore, PK; Ng, DS; Peh, MT, 2014) |
| "Atherosclerosis is an important cardiovascular disease, becoming a major and increasing health problem in developed countries." | 1.37 | Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice. ( Chen, ZF; DU, JB; Jin, HF; Li, W; Tang, CS; Tang, XY; Zhao, B; Zhu, LL, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (8.47) | 29.6817 |
| 2010's | 44 (74.58) | 24.3611 |
| 2020's | 10 (16.95) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z | 2 |
| Ouyang, C | 1 |
| Zhang, H | 3 |
| Gu, Y | 2 |
| Deng, Y | 1 |
| Du, C | 1 |
| Cui, C | 3 |
| Li, S | 2 |
| Wang, W | 3 |
| Kong, W | 1 |
| Chen, J | 1 |
| Cai, J | 3 |
| Geng, B | 3 |
| Tian, Z | 1 |
| Deng, NH | 1 |
| Zhou, ZX | 1 |
| Ren, Z | 2 |
| Xiong, WH | 1 |
| Jiang, ZS | 3 |
| Zhu, C | 1 |
| Liu, Q | 1 |
| Li, X | 1 |
| Wei, R | 1 |
| Ge, T | 1 |
| Zheng, X | 1 |
| Li, B | 1 |
| Liu, K | 1 |
| Cui, R | 1 |
| Munteanu, C | 1 |
| Bechelli, C | 1 |
| Macabrey, D | 1 |
| Deglise, S | 1 |
| Allagnat, F | 1 |
| Merz, T | 1 |
| Denoix, N | 1 |
| Wigger, D | 1 |
| Waller, C | 1 |
| Wepler, M | 1 |
| Vettorazzi, S | 1 |
| Tuckermann, J | 1 |
| Radermacher, P | 1 |
| McCook, O | 1 |
| Blachier, F | 1 |
| Andriamihaja, M | 1 |
| Blais, A | 1 |
| Gui, DD | 1 |
| Luo, W | 1 |
| Yan, BJ | 1 |
| Tang, ZH | 2 |
| Liu, LS | 1 |
| Zhang, JF | 1 |
| Jiang, S | 2 |
| Xu, W | 1 |
| Fan, X | 1 |
| Gong, Y | 1 |
| Hu, HJ | 1 |
| Qiu, J | 1 |
| Zhang, C | 1 |
| Qu, SL | 1 |
| Wang, ZJ | 1 |
| Wu, J | 1 |
| Guo, W | 1 |
| Zhu, YZ | 2 |
| Cheung, SH | 2 |
| Lau, JYW | 1 |
| Huang, YQ | 1 |
| Tang, CS | 2 |
| Du, JB | 3 |
| Jin, HF | 3 |
| Xue, WL | 1 |
| Cai, WJ | 1 |
| Tao, BB | 1 |
| Wang, MJ | 1 |
| Li, XH | 1 |
| Zhu, YC | 1 |
| Bibli, SI | 1 |
| Hu, J | 1 |
| Sigala, F | 1 |
| Wittig, I | 1 |
| Heidler, J | 1 |
| Zukunft, S | 1 |
| Tsilimigras, DI | 1 |
| Randriamboavonjy, V | 1 |
| Wittig, J | 1 |
| Kojonazarov, B | 1 |
| Schürmann, C | 1 |
| Siragusa, M | 1 |
| Siuda, D | 1 |
| Luck, B | 1 |
| Abdel Malik, R | 1 |
| Filis, KA | 1 |
| Zografos, G | 1 |
| Chen, C | 1 |
| Wang, DW | 1 |
| Pfeilschifter, J | 1 |
| Brandes, RP | 1 |
| Szabo, C | 2 |
| Papapetropoulos, A | 2 |
| Fleming, I | 1 |
| Yue, LM | 1 |
| Gao, YM | 1 |
| Han, BH | 1 |
| Barton, M | 1 |
| Meyer, MR | 1 |
| Esse, R | 1 |
| Barroso, M | 1 |
| Tavares de Almeida, I | 1 |
| Castro, R | 1 |
| Fan, J | 1 |
| Zheng, F | 1 |
| Zhang, J | 3 |
| Cui, Q | 1 |
| Yang, J | 1 |
| Tang, X | 3 |
| Xu, G | 1 |
| Bai, Z | 1 |
| Zhang, Q | 1 |
| Wang, Y | 3 |
| Li, J | 2 |
| Zhao, Q | 1 |
| Wang, Z | 1 |
| He, D | 1 |
| Liu, B | 1 |
| Mani, S | 2 |
| Untereiner, A | 2 |
| Wu, L | 2 |
| Wang, R | 3 |
| Bir, SC | 1 |
| Kevil, CG | 1 |
| Li, H | 3 |
| Yang, G | 1 |
| Austin, RC | 2 |
| Dickhout, JG | 1 |
| Lhoták, Š | 1 |
| Meng, QH | 1 |
| Xu, S | 1 |
| Liu, Z | 1 |
| Liu, P | 1 |
| Peh, MT | 1 |
| Anwar, AB | 1 |
| Ng, DS | 1 |
| Atan, MS | 1 |
| Kumar, SD | 1 |
| Moore, PK | 3 |
| Jain, SK | 1 |
| Huning, L | 1 |
| Micinski, D | 1 |
| Liu, X | 1 |
| Ma, D | 1 |
| Zheng, S | 3 |
| Zha, K | 1 |
| Feng, J | 1 |
| Cai, Y | 1 |
| Jiang, F | 1 |
| Fan, Z | 1 |
| Kwok, WK | 1 |
| To, KF | 1 |
| Lau, JY | 1 |
| Vacek, TP | 1 |
| Rehman, S | 1 |
| Neamtu, D | 1 |
| Yu, S | 1 |
| Givimani, S | 1 |
| Tyagi, SC | 1 |
| Lupoli, R | 1 |
| Di Minno, A | 1 |
| Spadarella, G | 1 |
| Franchini, M | 1 |
| Sorrentino, R | 1 |
| Cirino, G | 1 |
| Di Minno, G | 1 |
| Feng, SJ | 2 |
| Zhang, XD | 1 |
| Wang, SX | 2 |
| Huang, CW | 1 |
| Li, W | 7 |
| Du, J | 5 |
| Jin, H | 6 |
| Xie, L | 1 |
| Wen, M | 1 |
| Zhao, S | 1 |
| Ma, Y | 1 |
| Meng, G | 1 |
| Han, Y | 1 |
| Liu, G | 1 |
| Wang, X | 1 |
| Wang, H | 1 |
| Zhang, Z | 1 |
| Yu, Y | 1 |
| Ferro, A | 1 |
| Huang, Z | 1 |
| Ji, Y | 1 |
| Durante, W | 1 |
| Stroot, PG | 1 |
| Kanagy, NL | 1 |
| Caprnda, M | 1 |
| Qaradakhi, T | 1 |
| Hart, JL | 1 |
| Kobyliak, N | 1 |
| Opatrilova, R | 1 |
| Kruzliak, P | 1 |
| Zulli, A | 1 |
| Zhao, X | 1 |
| Wei, H | 1 |
| Bu, D | 1 |
| Ren, Y | 1 |
| Tang, C | 3 |
| Jeney, V | 1 |
| Komódi, E | 1 |
| Nagy, E | 1 |
| Zarjou, A | 1 |
| Vercellotti, GM | 1 |
| Eaton, JW | 1 |
| Balla, G | 1 |
| Balla, J | 1 |
| Qiao, W | 1 |
| Chaoshu, T | 1 |
| Hongfang, J | 1 |
| Junbao, D | 1 |
| Chen, SJ | 1 |
| Yan, XH | 1 |
| Zhu, XY | 1 |
| Hu, M | 1 |
| Hu, SG | 1 |
| Yuan, WJ | 1 |
| Bełtowski, J | 1 |
| Jamroz-Wiśniewska, A | 1 |
| Tokarzewska, D | 1 |
| Lavu, M | 1 |
| Bhushan, S | 1 |
| Lefer, DJ | 1 |
| Lynn, EG | 1 |
| Pan, LL | 1 |
| Liu, XH | 1 |
| Zheng, HM | 1 |
| Yang, HB | 1 |
| Gong, QH | 1 |
| Chen, ZF | 1 |
| Zhao, B | 1 |
| Tang, XY | 1 |
| Zhu, LL | 1 |
| Guo, C | 2 |
| Wu, D | 2 |
| Zhang, A | 2 |
| Gu, T | 2 |
| Wang, L | 1 |
| Wang, C | 2 |
| Zhou, K | 2 |
| Gao, Q | 2 |
| Pan, S | 1 |
| Li, P | 2 |
| Suo, K | 2 |
| Simoncini, T | 2 |
| Wang, T | 2 |
| Fu, X | 2 |
| Fan, Y | 1 |
| Sparatore, A | 1 |
| Chen, H | 1 |
| Zhang, Y | 1 |
| Chen, B | 1 |
| Lv, C | 1 |
| Zhao, M | 1 |
| Zhang, L | 1 |
| Laggner, H | 1 |
| Muellner, MK | 1 |
| Schreier, S | 1 |
| Sturm, B | 1 |
| Hermann, M | 1 |
| Exner, M | 1 |
| Gmeiner, BM | 1 |
| Kapiotis, S | 1 |
| Chung, HT | 1 |
| Pae, HO | 1 |
| Cha, YN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Short-Term Endogenous Hydrogen Sulfide Upregulation For Vein Graft Disease[NCT05457881] | 226 participants (Anticipated) | Interventional | 2024-03-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
19 reviews available for hydrogen sulfide and Atherogenesis
| Article | Year |
|---|---|
The role of adipose tissue-derived hydrogen sulfide in inhibiting atherosclerosis.
Topics: Adipose Tissue; Atherosclerosis; Cystathionine gamma-Lyase; Endothelial Cells; Humans; Hydrogen Sulf | 2022 |
Hydrogen sulfide: A new therapeutic target in vascular diseases.
Topics: Atherosclerosis; Humans; Hydrogen Sulfide; Hypertension; Inflammation; Signal Transduction | 2022 |
Hydrogen Sulfide and Oxygen Homeostasis in Atherosclerosis: A Systematic Review from Molecular Biology to Therapeutic Perspectives.
Topics: Arteries; Atherosclerosis; Homeostasis; Humans; Hydrogen Sulfide; Molecular Biology; Nitric Oxide; O | 2023 |
Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease.
Topics: Atherosclerosis; Humans; Hydrogen Sulfide; Myocardial Infarction; Peripheral Arterial Disease; Quali | 2023 |
Sulfur-Containing Amino Acids and Lipid Metabolism.
Topics: Amino Acids, Sulfur; Animals; Atherosclerosis; Betaine; Cholesterol; Cysteine; Dietary Proteins; Die | 2020 |
Effects of gut microbiota on atherosclerosis through hydrogen sulfide.
Topics: Animals; Arteries; Atherosclerosis; Bacteria; Gasotransmitters; Gastrointestinal Microbiome; Humans; | 2021 |
Atherosclerosis and the Hydrogen Sulfide Signaling Pathway - Therapeutic Approaches to Disease Prevention.
Topics: Animals; Antioxidants; Atherosclerosis; Epigenesis, Genetic; Gasotransmitters; Humans; Hydrogen Sulf | 2017 |
[Cardiovascular Regulation by Sulfur-containing Gaseous Signaling Molecules and the Underlying Mechanisms:Updated Research Evidence].
Topics: Animals; Atherosclerosis; Calcium Channels, L-Type; Cardiovascular System; Hydrogen Sulfide; Hyperte | 2017 |
[The Molecular Switches and Atomic Biological Mechanisms Underlying the Physiological and Pathophysio-logical Effects of Hydrogen Sulfide to Regulate Its "Receptors"].
Topics: Asthma; Atherosclerosis; Carbon Monoxide; Cardiovascular System; Humans; Hydrogen Sulfide; Hypertens | 2017 |
The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art.
Topics: Atherosclerosis; Cardiovascular Diseases; Endothelial Cells; Homocysteine; Humans; Hydrogen Sulfide; | 2019 |
Hydrogen sulfide and the pathogenesis of atherosclerosis.
Topics: Animals; Antioxidants; Atherosclerosis; Endothelium, Vascular; Humans; Hydrogen Sulfide; Muscle, Smo | 2014 |
Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.
Topics: Animals; Atherosclerosis; Carbon Dioxide; Cystathionine gamma-Lyase; Humans; Hydrogen Sulfide; Mice; | 2014 |
Matrix metalloproteinases in atherosclerosis: role of nitric oxide, hydrogen sulfide, homocysteine, and polymorphisms.
Topics: Animals; Atherosclerosis; Blood Vessels; Enzyme Activation; Genetic Predisposition to Disease; Homoc | 2015 |
Methylation reactions, the redox balance and atherothrombosis: the search for a link with hydrogen sulfide.
Topics: Animals; Aspirin; Atherosclerosis; Folic Acid; Gasotransmitters; Homocysteine; Humans; Hydrogen Sulf | 2015 |
H2S Synthesizing Enzymes: Biochemistry and Molecular Aspects.
Topics: Animals; Asthma; Atherosclerosis; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Diabetes M | 2015 |
Vascular biology of hydrogen sulfide.
Topics: Animals; Arteries; Atherosclerosis; Humans; Hydrogen Sulfide; Models, Cardiovascular; Neovasculariza | 2017 |
Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis.
Topics: Atherosclerosis; Blood Platelets; Calcinosis; Cell Proliferation; Humans; Hydrogen Sulfide; Hyperhom | 2010 |
Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential.
Topics: Angiogenesis Inducing Agents; Animals; Atherosclerosis; Endothelium, Vascular; Humans; Hydrogen Sulf | 2011 |
Role of heme oxygenase-1 in vascular disease.
Topics: Animals; Atherosclerosis; Carbon Monoxide; Endothelium, Vascular; Enzyme Induction; Heme Oxygenase-1 | 2008 |
40 other studies available for hydrogen sulfide and Atherogenesis
| Article | Year |
|---|---|
Vascular smooth muscle cell-derived hydrogen sulfide promotes atherosclerotic plaque stability via TFEB (transcription factor EB)-mediated autophagy.
Topics: Atherosclerosis; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Biomarkers; | 2022 |
The Role of Glucocorticoid Receptor and Oxytocin Receptor in the Septic Heart in a Clinically Relevant, Resuscitated Porcine Model With Underlying Atherosclerosis.
Topics: Animals; Atherosclerosis; Cystathionine gamma-Lyase; Disease Models, Animal; Gene Expression Regulat | 2020 |
Hydrogen sulphide reduces hyperhomocysteinaemia-induced endothelial ER stress by sulfhydrating protein disulphide isomerase to attenuate atherosclerosis.
Topics: Animals; Atherosclerosis; Cell Line; Disease Models, Animal; Endoplasmic Reticulum Stress; Endotheli | 2021 |
Hydrogen sulfide improves ox‑LDL‑induced expression levels of Lp‑PLA
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Atherosclerosis; Cystathionine gamma-Lyase; Foam Cel | 2021 |
Hydrogen sulfide mediates athero-protection against oxidative stress via S-sulfhydration.
Topics: Animals; Atherosclerosis; Disease Models, Animal; Glutathione Peroxidase; Glutathione Peroxidase GPX | 2018 |
Cystathionine γ Lyase Sulfhydrates the RNA Binding Protein Human Antigen R to Preserve Endothelial Cell Function and Delay Atherogenesis.
Topics: Aged; Aged, 80 and over; Animals; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Cathep | 2019 |
Evaluation on the effect of hydrogen sulfide on the NLRP3 signaling pathway and its involvement in the pathogenesis of atherosclerosis.
Topics: Animals; Atherosclerosis; CARD Signaling Adaptor Proteins; Carrier Proteins; Caspase 1; Cell Line, T | 2019 |
HuR-ry Up: How Hydrogen Sulfide Protects Against Atherosclerosis.
Topics: Atherosclerosis; Cystathionine gamma-Lyase; Endothelial Cells; Humans; Hydrogen Sulfide; RNA-Binding | 2019 |
Hydrogen sulfide lowers hyperhomocysteinemia dependent on cystathionine γ lyase S-sulfhydration in ApoE-knockout atherosclerotic mice.
Topics: Animals; Atherosclerosis; Cells, Cultured; Cystathionine gamma-Lyase; Disease Models, Animal; Dose-R | 2019 |
Anti-atherosclerosis effect of H
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Atherosclerosis; Cell Line; Cell Pro | 2019 |
Sulfane sustains vascular health: insights into cystathionine γ-lyase function.
Topics: Animals; Atherosclerosis; Cystathionine gamma-Lyase; Female; Humans; Hydrogen Sulfide; Hypertension; | 2013 |
Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Proliferation; Cystathionine gamma-Lyase; Disease | 2013 |
Effect of feeding a high fat diet on hydrogen sulfide (H2S) metabolism in the mouse.
Topics: Animals; Aorta; Atherosclerosis; Cystathionine beta-Synthase; Cystathionine gamma-Lyase; Cytokines; | 2014 |
Hydrogen sulfide upregulates glutamate-cysteine ligase catalytic subunit, glutamate-cysteine ligase modifier subunit, and glutathione and inhibits interleukin-1β secretion in monocytes exposed to high glucose levels.
Topics: Atherosclerosis; Catalytic Domain; Cell Survival; Enzyme-Linked Immunosorbent Assay; Glucose; Glutam | 2014 |
The roles of nitric oxide and hydrogen sulfide in the anti-atherosclerotic effect of atorvastatin.
Topics: Alkynes; Animals; Aorta, Thoracic; Atherosclerosis; Atorvastatin; Diet, High-Fat; Glycine; Heptanoic | 2015 |
Anti-atherogenic effect of hydrogen sulfide by over-expression of cystathionine gamma-lyase (CSE) gene.
Topics: Adiponectin; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Pressure; Body Weight; Cystat | 2014 |
Correlation of Lower Concentrations of Hydrogen Sulfide with Activation of Protein Kinase CβII in Uremic Accelerated Atherosclerosis Patients.
Topics: Adult; Aged; Atherosclerosis; Blotting, Western; Humans; Hydrogen Sulfide; Middle Aged; Protein Kina | 2015 |
[Suppressive effect of hydrogen sulfide donor on endothelin-1 production in aorta of atherosclerotic rats].
Topics: Animals; Aorta; Atherosclerosis; Coronary Vessels; Disease Models, Animal; Endothelin-1; Hydrogen Su | 2015 |
Lower Hydrogen Sulfide Is Associated with Cardiovascular Mortality, Which Involves cPKCβII/Akt Pathway in Chronic Hemodialysis Patients.
Topics: Adult; Atherosclerosis; Biomarkers; Blood Pressure; Carotid Arteries; Carotid Intima-Media Thickness | 2015 |
[Effects of hydrogen sulfide donor on production of adrenomedullin and atrial natriuretic peptide in rats with atherosclerosis].
Topics: Adrenomedullin; Animals; Atherosclerosis; Atrial Natriuretic Factor; Hydrogen Sulfide; Male; Rats; R | 2015 |
Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation.
Topics: Active Transport, Cell Nucleus; Animals; Atherosclerosis; Diabetes Mellitus; Female; Glucose; Heme O | 2016 |
Hydrogen Sulfide Therapy in Diabetes-Accelerated Atherosclerosis: A Whiff of Success.
Topics: Atherosclerosis; Diabetes Mellitus; Humans; Hydrogen Sulfide | 2016 |
Blood oxidative stress (BLOS) is a secondary host defense system responding normally to anaerobic wound infection and inadvertently to dietary ultra-exogenous sulfide formation (USF).
Topics: Anaerobiosis; Animals; Atherosclerosis; Bacterial Infections; Blood Component Removal; Blood Glucose | 2017 |
H
Topics: Acetylcholine; Animals; Arteries; Atherosclerosis; Homocysteine; Hydrogen Sulfide; In Vitro Techniqu | 2017 |
Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
Topics: Active Transport, Cell Nucleus; Alkynes; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Body We | 2009 |
Is H2S a stinky remedy for atherosclerosis?
Topics: Animals; Aorta; Atherosclerosis; Cardiovascular Agents; Cystathionine gamma-Lyase; Endothelial Cells | 2009 |
Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H(2)S).
Topics: Atherosclerosis; Cell Death; Cell Line; Cytoprotection; Endothelial Cells; Hemin; Humans; Hydrogen S | 2009 |
[Effect of hydrogen sulfide on antiatherosclerosis in rats].
Topics: Animals; Atherosclerosis; Cholecalciferol; Dietary Fats; Hydrogen Sulfide; Lipids; Male; Rats; Rats, | 2010 |
Hydrogen sulfide and its modulation in arterial hypertension and atherosclerosis.
Topics: Animals; Atherosclerosis; Blood Pressure; Body Fluids; Humans; Hydrogen Sulfide; Hypertension; Mice; | 2010 |
Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential.
Topics: Animals; Atherosclerosis; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Humans | 2011 |
Regulatory effects of sulfur dioxide on the development of atherosclerotic lesions and vascular hydrogen sulfide in atherosclerotic rats.
Topics: Animals; Aorta; Aspartate Aminotransferases; Atherosclerosis; Cystathionine gamma-Lyase; Glutathione | 2011 |
Effects of onion extract on endogenous vascular H2S and adrenomedulin in rat atherosclerosis.
Topics: Adrenomedullin; Animals; Aorta; Atherosclerosis; Calcitonin Receptor-Like Protein; Coronary Vessels; | 2011 |
S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuated tumor necrosis factor-α-induced inflammatory signaling and dysfunction in endothelial cells.
Topics: Atherosclerosis; Cysteine; Endothelial Cells; Garlic; Human Umbilical Vein Endothelial Cells; Humans | 2012 |
Hydrogen sulfide regulates vascular endoplasmic reticulum stress in apolipoprotein E knockout mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Body Weight; Cholesterol; Endoplasmic Reticulum Chapero | 2011 |
Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression.
Topics: Animals; Aorta; Atherosclerosis; Catalysis; Chemokine CX3CL1; Chemotaxis; CX3C Chemokine Receptor 1; | 2012 |
17β-estradiol induces vasorelaxation by stimulating endothelial hydrogen sulfide release.
Topics: Acetylcholine; Alkynes; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Cyclic GMP-Dependent Pro | 2013 |
Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice.
Topics: Animals; Apolipoproteins E; Aspirin; Atherosclerosis; Brachiocephalic Trunk; Cell Line; Chemotaxis; | 2012 |
17β-estradiol attenuates atherosclerosis development: the possible role of hydrogen sulfide.
Topics: Animals; Atherosclerosis; Cells, Cultured; Estradiol; Female; Human Umbilical Vein Endothelial Cells | 2013 |
Fluorescent probe for highly selective and sensitive detection of hydrogen sulfide in living cells and cardiac tissues.
Topics: Animals; Atherosclerosis; Cattle; Coumarins; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen Sulfide; | 2013 |
Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl.
Topics: Atherosclerosis; Chloramines; Electrophoresis; Humans; Hydrogen Peroxide; Hydrogen Sulfide; Hypochlo | 2007 |